Protagonist Therapeutics, Inc.PTGXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+11.9%
5Y CAGR+19.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+11.9%/yr
vs +23.4%/yr prior
5Y CAGR
+19.0%/yr
Recent deceleration
Acceleration
-11.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44.48M | +2.3% |
| 2024 | $43.46M | +29.8% |
| 2023 | $33.49M | +5.5% |
| 2022 | $31.74M | +16.7% |
| 2021 | $27.20M | +45.9% |
| 2020 | $18.64M | +18.3% |
| 2019 | $15.75M | +15.0% |
| 2018 | $13.70M | +16.3% |
| 2017 | $11.78M | +69.2% |
| 2016 | $6.96M | - |